| Heading: |
Medical Treatments and Tofersen |
| Question ID: |
1807623 |
| UIN: |
56055 |
| House: |
Commons |
| Date tabled: |
2025-05-30 |
| Asking Member ID: |
5241 |
| Asking Member display name: |
Aphra Brandreth
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Aphra Brandreth
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that variations in local NHS (a) capacity and (b) resourcing of (i) Early Access Programmes and (ii) the availability of tofersen support the reduction |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and Healthcare products Regulatory Agency has received the application for tofersen and is currently reviewing it rapidly for quality, safety, and efficacy, for use in the United Kingdom.The National Institute for Health and Care Excellence ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |